P48.03 Spectrum of Resistance Mechanisms to First, Second and Third Generation Tyrosine Kinase Inhibitors in EGFR Mutant NSCLC Patients
Year: 2021
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: M. Suryavanshi, S. Mattoo, S. Dhandha, A. Mehta, U. Batra
Institution: Rajiv Gandhi Cancer Institute and Research Centre
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3207385201